Hennion & Walsh Asset Management’s Edwards Lifesciences EW Stock Holding History

Hennion & Walsh Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$841K	Sell	9,292 -162	-2%	-$13.6K	0.02%	612
2026 Q1	$757K	Buy	9,454 +1,224	+15%	+$101K	0.03%	577
2025 Q4	$702K	Buy	+8,230	New	+$675K	0.02%	612
2022 Q1	–	Sell	-1,811	Closed	-$235K	–	785
2021 Q4	$235K	Sell	1,811 -1,743	-49%	-$203K	0.01%	690
2021 Q3	$402K	Sell	3,554 -1,418	-29%	-$162K	0.02%	557
2021 Q2	$515K	Sell	4,972 -4	-0.1%	-$377	0.03%	517
2021 Q1	$416K	Buy	+4,976	New	+$421K	0.03%	532

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Hennion & Walsh Asset Management's EW Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Edwards Lifesciences (EW) stake by 1.7% in Q2 2026, selling an estimated $13.6K and leaving 9,292 shares worth $841K. The position accounts for 0.02% of the portfolio, ranked #612.

Hennion & Walsh Asset Management first reported a position in EW in Q1 2021 and has held it in 7 quarters since. 302 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Hennion & Walsh Asset Management held 9,292 shares of Edwards Lifesciences worth $841K as of Q2 2026.
Hennion & Walsh Asset Management sold 162 Edwards Lifesciences shares in Q2 2026, an estimated $13.6K.
Edwards Lifesciences made up 0.02% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #612 holding.
Hennion & Walsh Asset Management first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 7 quarters since.
302 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.